Human Aflatoxin B1 Aldehyde Reductase Member 3 (AKR7A3) Enzyme

Este producto es parte de AKR7 - Aflatoxin B1 aldehyde reductase member
Product Graph
234€ (2 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human Aflatoxin B1 Aldehyde Reductase Member 3 (AKR7A3) Enzyme
category
Proteins and Peptides
provider
Abbexa
reference
abx073769
tested applications
SDS-PAGE

Description

Aldo-Keto Reductase Family 7 Member A3 is a recombinant enzyme.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Aflatoxin B1 Aldehyde Reductase Member 3 (AKR7A3)
Host
E. coli
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Origin
Human
Expression
Recombinant
Purity
> 95% (SDS-PAGE)
Size 1
2 µg
Size 2
10 µg
Size 3
1 mg
Form
Liquid
Tested Applications
SDS-PAGE
Availability
Shipped within 5-10 working days.
Storage
Store at 4 °C if the entire vial will be used within 2-4 weeks. Store at -20 °C for long term storage. For long term storage, it is recommended to add a carrier protein (0.1% HSA or BSA). Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
O95154
Alias
AKR7A3,AFAR2
Background
Protein AKR7A3
Status
RUO
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

AKR7A3 shares significant structural and functional similarity with AKR7A2 and is involved in detoxifying aflatoxin B1-derived reactive aldehydes and other toxic carbonyl compounds. It functions as a critical enzyme in aldehyde metabolism, protecting cells from the damaging effects of reactive aldehydes produced during oxidative stress, lipid peroxidation, and xenobiotic metabolism. AKR7A3 is expressed in the liver and gastrointestinal tissues, where it contributes to the defense against dietary toxins, including aflatoxins and other environmental carcinogens. Its ability to detoxify lipid peroxidation products like 4-HNE and malondialdehyde highlights its role in preventing oxidative stress-related cellular damage and carcinogenesis. AKR7A3 also plays a role in maintaining liver homeostasis and mitigating toxin-induced liver injury. Dysregulation or reduced expression of AKR7A3 can increase susceptibility to liver cancer and chronic liver diseases by promoting the accumulation of reactive aldehydes and subsequent DNA damage. Emerging research focuses on its potential as a biomarker for toxin exposure and a target for improving antioxidant defenses in liver-related disorders.

Related Products

FNab00267

AKR7A3 antibody

Can reduce the dialdehyde protein-binding form of aflatoxin B1(AFB1) to the non-binding AFB1 dialcohol. May be involved in protection of liver against the toxic and carcinogenic effects of AFB1, a potent hepatocarcinogen.

Ver Producto
P4305

Recombinant Human AKR7A3

Ver Producto
abx005728

Aflatoxin B1 Aldehyde Reductase Member 3 (AKR7A3) Antibody

AKR7A3 Antibody is a Rabbit Polyclonal Antibody against AKR7A3.

Ver Producto